about
The clinical efficacy of artemether/lumefantrine (Coartem)Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data.Towards a proteomic definition of CoArtem action in Plasmodium falciparum malaria.Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmissionCommunity screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis.WHO, the Global Fund, and medical malpractice in malaria treatment.Falciparum malaria: current therapeutic challenges.The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysisEfficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria.Genesis of EDCTP2.European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership.A systematic review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission.Fighting HIV/AIDS, tuberculosis and malaria: one world, one partnership.Linking research and development to strengthen health systems in Africa
P50
Q21034141-21D9C830-0D5A-4D93-B48D-509E7306EBEBQ31043633-8484CFA2-DDB6-4084-A01F-4F81BF2E6562Q31160199-784A9A0C-F477-4C56-A8B8-6E1F1C3992A4Q33670134-DA988495-2068-4B40-9FBD-B88CD7D2478CQ34020818-814B4465-4F0A-467D-82F8-935D26AE3BDEQ35179184-742E2FC5-76A9-4090-B754-D2C83C36AF29Q35636073-E160033C-97CB-4FAB-8939-9C8A8FB17DA5Q35881130-456D846F-7D3A-4F18-AB14-272FC54E1BFBQ38529669-78828F7E-8A7A-4999-B0B1-0810D175B8A5Q38895510-181EAC8A-C989-4C2F-B851-5715D8B5F690Q40510491-5853777C-509D-4C5A-AB3B-81EC66502DF1Q41616166-31EE5004-A1E1-4069-BE46-AD46DE8C47EEQ42685665-EEA28A2D-FFBD-4B39-BAC9-2A95411E92CCQ45902300-7A4F194C-1822-4853-945A-C1C7E94F7A78Q47944535-FD464891-4FDF-458A-81EC-1C6860417095Q57165370-FBBD8FE4-7B75-473C-BF64-62054B776961
P50
name
Michael Makanga
@en
type
label
Michael Makanga
@en
prefLabel
Michael Makanga
@en